Pantec Biosolutions AG Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Pantec Biosolutions AG's estimated annual revenue is currently $4M per year.(i)
  • Pantec Biosolutions AG's estimated revenue per employee is $251,000

Employee Data

  • Pantec Biosolutions AG has 16 Employees.(i)
  • Pantec Biosolutions AG grew their employee count by -24% last year.

Pantec Biosolutions AG's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M40-18%$10MN/A
#2
$24.8M9929%N/AN/A
#3
$84.1M0N/A$1.2MN/A
#4
$35.6M14230%N/AN/A
#5
$57.5M2296%N/AN/A
#6
$52.7M16825%$129.6MN/A
#7
$21.1M84-3%N/AN/A
#8
$61.2M244-13%N/AN/A
#9
$60.6M19320%$115.5MN/A
#10
$56.2M179-3%$122.9MN/A
Add Company

What Is Pantec Biosolutions AG?

Pantec Biosolutions is the leading company for stable and controlled transdermal delivery of large weight biopharmaceuticals. Our goal is to replace injection based medication of biologicals in selected disease areas with the help of a breakthrough transdermal delivery method. The proprietary combination of P.L.E.A.S.E® microporation technology with transdermal patch technology allows easy to use, safe, rapid and painless application of infertility hormones and other large molecular weight biopharmaceuticals. This platform significantly improves drug uptake in addition to reducing treatment duration and avoiding the need for injections. This technology has significant potential to unlock a high unmet need of treatments requiring large molecular weight biopharmaceuticals.

keywords:N/A

N/A

Total Funding

16

Number of Employees

$4M

Revenue (est)

-24%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Pantec Biosolutions AG News

2022-04-17 - Le marché de l'administration transmuqueuse de ...

... TEVA Pharmaceutical Industries Ltd., Aveva Drug Delivery Systems, Corium International, Inc, ALZA Corporation, Pantec Biosolutions AG,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2M16-20%N/A
#2
$0.9M160%$25M
#3
$1.4M16-38%N/A
#4
$3.5M1623%N/A
#5
$3.5M16-33%N/A